These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16240558)

  • 1. Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine.
    Hurt RD; Patten CA; Offord KP; Croghan IT; Decker PA; Morris RA; Hays JT
    J Stud Alcohol; 2005 Jul; 66(4):506-16. PubMed ID: 16240558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels.
    Fredrickson PA; Hurt RD; Lee GM; Wingender L; Croghan IT; Lauger G; Gomez-Dahl L; Offord KP
    Psychopharmacology (Berl); 1995 Dec; 122(3):215-22. PubMed ID: 8748390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.
    Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS
    J Clin Pharmacol; 1998 Jun; 38(6):502-9. PubMed ID: 9650539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
    Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes.
    Kalman D; Kahler CW; Garvey AJ; Monti PM
    J Subst Abuse Treat; 2006 Apr; 30(3):213-7. PubMed ID: 16616165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects.
    Ogburn PL; Hurt RD; Croghan IT; Schroeder DR; Ramin KD; Offord KP; Moyer TP
    Am J Obstet Gynecol; 1999 Sep; 181(3):736-43. PubMed ID: 10486492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine patch therapy in adolescent smokers.
    Smith TA; House RF; Croghan IT; Gauvin TR; Colligan RC; Offord KP; Gomez-Dahl LC; Hurt RD
    Pediatrics; 1996 Oct; 98(4 Pt 1):659-67. PubMed ID: 8885942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.
    Hays JT; Hurt RD; Decker PA; Croghan IT; Offord KP; Patten CA
    Nicotine Tob Res; 2009 Jul; 11(7):859-67. PubMed ID: 19483180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postintervention effect of nicotine replacement therapy for smoking reduction: a randomized trial with a 5-year follow-up.
    Etter JF; Laszlo E
    J Clin Psychopharmacol; 2007 Apr; 27(2):151-5. PubMed ID: 17414237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men.
    Mabry PL; Tooze JA; Moser RP; Augustson EM; Malcolm RJ; Benowitz NL
    Nicotine Tob Res; 2007 Jan; 9(1):65-82. PubMed ID: 17365738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term nicotine replacement therapy: a randomized clinical trial.
    Schnoll RA; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Wileyto EP; Hitsman B
    JAMA Intern Med; 2015 Apr; 175(4):504-11. PubMed ID: 25705872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal nicotine use in postmenopausal women: does the treatment efficacy differ in women using and not using hormone replacement therapy?
    Allen SS; Hatsukami DK; Bade T; Center B
    Nicotine Tob Res; 2004 Oct; 6(5):777-88. PubMed ID: 15700913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone and nicotine patch smoking cessation: a preliminary study.
    Krishnan-Sarin S; Meandzija B; O'Malley S
    Nicotine Tob Res; 2003 Dec; 5(6):851-7. PubMed ID: 14750508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.
    Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS
    J Clin Pharmacol; 1998 Jun; 38(6):510-6. PubMed ID: 9650540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.